6 Paid Clinical Research Studies in Springdale, Arkansas
Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
Urothelial carcinoma (UC) is the ninth most common cancer type worldwide. While the treatment of front-line metastatic urothelial carcinoma (mUC) has improved, there remains a high
📍 Highlands Oncology Group - Springdale /ID# 270290 — Springdale, Arkansas
💵 In arm 1, participants will receive intravenously (IV) infused livmoniplimab (dose A) in combination with IV infused bud
View Study & Checklist ➔Food Provision in Prenatal Care
The overarching research question is: "Does the provision of healthy food during pregnancy reduce the proportion of women who experience excessive gestational weight gain compared
📍 UAMS Institute for Community Health Innovation — Springdale, Arkansas
View Study & Checklist ➔Study of LP-184 in Patients With Advanced Solid Tumors
The primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory
📍 Highlands Oncology Group — Springdale, Arkansas
💵 Participants will receive LP-184 infusion during Day 1 and Day 8 of each 21-day cycle, for a minimum of two cycles.
View Study & Checklist ➔ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
This is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatment group. This trial
📍 Highlands Oncology Group — Springdale, Arkansas
💵 Participants will receive either the trial drug with chemotherapy or placebo (which looks like the trial drug but does n
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and
📍 Highlands Oncology Group - Springdale /ID# 277132 — Springdale, Arkansas
💵 This study will be divided into two stages, in the first stage (phase 2) participants will receive 1 of 2 doses of telis
View Study & Checklist ➔Family Model DSME in FBOs in the RMI
Health disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Isla
📍 UAMS Institute for Community Health Innovation — Springdale, Arkansas
View Study & Checklist ➔